Nathan Rice
Stock Analyst at Piper Sandler
(4.30)
# 455
Out of 4,761 analysts
51
Total ratings
63.64%
Success rate
13.93%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Maintains: Overweight | $53 → $57 | $41.47 | +36.24% | 7 | Jan 30, 2025 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $46 → $47 | $37.82 | +24.27% | 3 | Nov 1, 2024 | |
| BY Byline Bancorp | Reiterates: Overweight | $34 | $28.91 | +17.61% | 8 | Oct 29, 2024 | |
| BFC Bank First | Maintains: Neutral | $99 → $104 | $102.52 | +1.44% | 5 | Oct 17, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $63.48 | +16.57% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $117.03 | -28.22% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $190.43 | +3.45% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $11.02 | -18.33% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $452.77 | -3.92% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $299.81 | -22.28% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $57.68 | +43.90% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $18.33 | -18.17% | 1 | Dec 19, 2019 |
Merchants Bancorp
Jan 30, 2025
Maintains: Overweight
Price Target: $53 → $57
Current: $41.47
Upside: +36.24%
First Mid Bancshares
Nov 1, 2024
Maintains: Overweight
Price Target: $46 → $47
Current: $37.82
Upside: +24.27%
Byline Bancorp
Oct 29, 2024
Reiterates: Overweight
Price Target: $34
Current: $28.91
Upside: +17.61%
Bank First
Oct 17, 2024
Maintains: Neutral
Price Target: $99 → $104
Current: $102.52
Upside: +1.44%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $63.48
Upside: +16.57%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $117.03
Upside: -28.22%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $190.43
Upside: +3.45%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $11.02
Upside: -18.33%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $452.77
Upside: -3.92%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $299.81
Upside: -22.28%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $57.68
Upside: +43.90%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $18.33
Upside: -18.17%